Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CRAFT: Cryoablation vs Antiarrhythmic Drugs for Persistent AF
NCT03716934Phase 4Completed
- Sponsor
- Hospital Clínico San Carlos
- Start
- Jun 2018
- Primary completion
- Apr 2022
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial (2 arms), sponsored by Hospital Clínico San Carlos. Primary endpoints: Survival time with atrial fibrillation, auricular flutter or tachycardia at 9 months and Presence of death or one major complications at 13 months. Started Jun 2018; status: completed.
Beyond the preview
Go deeper on NCT03716934.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03716934.